The urological group of the EORTC (European Organization for Research on the Treatment of Cancer) , 1976-1984
Smith, P.H.; de Pauw, M.; Sylvester, R.
Archivos Espanoles de Urologia 37 Suppl. 2: 713-723
1984
ISSN/ISBN: 0004-0614 PMID: 6543605 Document Number: 231781
Document emailed within 1 workday
Related Documents
Buesa, J.M.; Mouridsen, H.T.; Santoro, A.; Somers, R.; Bramwell, V.; van Oosterom, A.T.; Wagener, T.; Vendrik, C.; Thomas, D. 1984: Treatment of advanced soft tissue sarcomas with low-dose methotrexate: a phase Ii trial by the European Organization of Research on Treatment for Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Cancer Treatment Reports 68(4): 683-684Bollack, C.; Jacqmin, D.; Splinter, T.A.; De Pauw, M. 1988: Non-adjuvant chemotherapy of bladder neoplasms stage T3-4 using NO-x and MO. Preliminary results of the urogenital study group of the European Organization for Research and Treatment of Cancer Casopis Lekaru Ceskych 127(35): 1098-1100
Wagener, D.J.; van Oosterom, A.T.; Mulder, J.H.; Somers, R.; Mouridsen, H.T.; Cortes Funes, H.; Thomas, D.; Sylvester, R. 1986: Phase II study of low-dose methotrexate in advanced osteosarcoma followed by escalation after disease progression: a study of the Soft Tissue and Bone Sarcoma Group of the European Organization for Research on Treatment of Cancer Cancer Treatment Reports 70(5): 615-618
Van Zandwijk, N.; Dalesio, O. 1994: Platinum-based chemotherapy in non-small cell lung cancer: the experience of the European Organization for the Research and Treatment of Cancer Seminars in Oncology 21(3 Suppl 6: 66-71
Sirisinha, T.; Ratanatharathorn, V.; Jirajarus, M.; Sirilerttrakul, S.; Silpakit, C.; Sirachainan, E.; Tanvetyanon, T. 2002: The European Organization for Research and Treatment of Cancer quality of life questionnaire: translation and reliability study of the Thai version Journal of the Medical Association of Thailand 85(11): 1210-1219
Denis, L.; Smith, P.; Carneiro de Moura, J.L.; Newling, D.; Bono, A.; Keuppens, F.; Mahler, C.; Robinson, M.; Sylvester, R.; De Pauw, M. 1991: Total androgen ablation: European experience. the EORTC GU Group Urologic Clinics of North America 18(1): 65-73
Jakse, G. 1989: Intravesical instillation of BCG in carcinoma in situ of the urinary bladder. EORTC protocol 30861. EORTC-GU Group Progress in Clinical and Biological Research 310: 187-192
Zittoun, R.; Mandelli, F.; Willemze, R.; de Witte, T.; Tura, S.; Ferrini, P.R.; Stryckmans, P.; Gattringer, C.; Petti, M.C.; Solbu, G. 1992: Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase IIi trial (AML8 A). the EORTC Leukemia Cooperative Group and the GIMEMA Group Leukemia 6(Suppl 2): 114-115
Suciu, S.; Solbu, G.; Zittoun, R.; Hayat, M.; Willemze, R.; de Witte, T.; Mandelli, F. 1991: Methodology of evaluation in EORTC trials including BMT in acute myelogenous leukemia (AML) in first complete remission (CR). EORTC Leukemia Cooperative Group (LCG) and GIMEMA Bone Marrow Transplantation 7(Suppl 2): 34
van Breukelen, F.J.; Mattson, K.; Giaccone, G.; van Zandwijk, N.; Planteydt, H.T.; Kirkpatrick, A.; Dalesio, O. 1991: Mitoxantrone in malignant pleural mesothelioma: a study by the EORTC Lung Cancer Cooperative Group European Journal of Cancer 27(12): 1627-1629
O'Higgins, N.; Linos, D.A.; Blichert-Toft, M.; Cataliotti, L.; de Wolf, C.; Rochard, F.; Rutgers, E.J.; Roberts, P.J.; Mattheiem, W.; da Silva, M.A.; Holmberg, L.; Schulz, K.D.; Smola, M.G.; Mansel, R.E. 1998: European guidelines for quality assurance in the surgical management of mammographically detected lesions. European Breast Cancer Working Group Annales Chirurgiae et Gynaecologiae 87(1): 110-112
1971: Carcinoma of the prostate. Clinical trial results. The Veterans Administration Co-operative Urological Research Group Minnesota Medicine 5(7): 511-514
Gerhartz, H.H.; Visani, G.; Delmer, A.; Zwierzina, H.; Ribeiro, M.; Jacobs, A.; Marcus, R.; Baumelou, M.; Fière, D.; Labar, B. 1989: Low-dose Ara-C plus granulocyte/macrophage colony-stimulating factor for the treatment of myelodysplastic syndromes. EORTC Leukemia Group Bone Marrow Transplantation 4(Suppl 3): 36-37
Vitali, C.; Bencivelli, W.; Isenberg, D.A.; Smolen, J.S.; Snaith, M.L.; Sciuto, M.; Neri, R.; Bombardieri, S. 1992: Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE Clinical and Experimental Rheumatology 10(5): 541-547
Loprinzi, C.L.; Miser, A.W.; Kardinal, C.; Everson, L.K.; Ahlquist, D.A.; Dose, A.M.; Moertel, C.G. 1989: Cancer control research in the North Central Cancer Treatment Group (NCCTG) Progress in Clinical and Biological Research 293: 345-353
Sansoni, J. 1997: From Europe: nursing research. The association is representing the Italian nurses within the European Group of Research Nurses Professioni Infermieristiche 50(1): 55-56
Moser, E.C.; Noordijk, E.M.; van Leeuwen, F.E.; Baars, J.W.; Thomas, Jé.; Carde, P.; Meerwaldt, J.H.; van Glabbeke, M.; Kluin-Nelemans, H.C. 2006: Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study Haematologica 91(11): 1481-1488
Nabholtz, J.M.; Lindsay, M.A.; Hugh, J.; Mackey, J.; Smylie, M.; Au, H.J.; Tonkin, K.; Allen, M. 1999: The academic global virtual concept in clinical cancer research and its application to breast cancer: The Breast Cancer International Research Group Seminars in Oncology 26(3 Suppl. 8): 4-8
Bero, L.A.; Grilli, R.; Grimshaw, J.M.; Harvey, E.; Oxman, A.D.; Thomson, M.A. 1998: Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. the Cochrane Effective Practice and Organization of Care Review Group Bmj 317(7156): 465-468
Soffritti, M.; Chiozzotto, D.; Belpoggi, F. 2009: The role of scientific research in the identification of occupational carcinogenic agents: the contribution of the Cesare Maltoni Cancer research center of the European Ramazzini Foundation Epidemiologia e Prevenzione 33(4-5 Suppl 2: 57-67